Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MDT IDEs the robot in 2021. Expects approval 2 years from now.
Thanks for posting that. Wow. Quite interesting and ambitious .
That robot in that picture has two table connected arms. Tissue touch-and-feel feedback, the way they are describing it, combined with a training mode to handle various tissues seems to require pretty complex algorithms to me and hence requiring years of programming and verifying.
I doubt that this will be ready for FDA approvals in near future. It has an expert or a pseudo AI system in it and that has to be verified for all tissues in house and then by others. It is a great idea but I can't believe that it is fully functional and not error prone yet.
May need to wait for another decade before this thing matures. We don't even have a good self driving car yet and that is simpler than this.
Please feel free to disagree.
Regarding MDT robot, lets just wait and see their demo.
What is known: That robot is result of nearly 20 years of development if not more and still they have no FDA approvals and it looks like to be couple of generations older than the current market offerings if it is indeed as big as it looks in pictures posted here.
Maybe they are trying to test the market using uptown marketing schemes such as a reveal.
It is certainly not a single port and it is not a small multi arm either.
You have been lying and trying to cheat the longs for months and as long as I have been here. That is what is getting tiring. You don't have my trust and I guarantee you that no long here trusts you.
The reason you want it cheap is because you want to scoop, what else is there. .That is what is about. You want the stock to go dirt cheap so you can steal from the longs.
It is exactly the same crap sprout posted over and over and loaded lies about the management etc that you are now pumping is exactly how sprout was playing with series of lies one after another.
The fact that there are dilutions is no excuse to constantly lie.
The exchanges have surveillance and some unusual trading activities may triggers the halts I believe.
LOL. Obviously it is multi armed.
There was a release today that it is not FDA approved.
By the way, it is not going to a $1 because people are not going to sell on short's commands anymore.
There is no new shares yet and they are selling them to many investors and it is unlikely that they will dump
They did. You were claiming that they were going sell massive number shares that did not happen.
The company will be valued vastly more after approvals and capital markets will invest in it.
You can part ways after approvals if you feel that it is too costly but the uncommercialized robot is still very valuable.
I can't predict the future like everybody else here so I am not betting on rumors but what the company says.
I believe that this is a great robot of its time and its time is now and upon approvals, it will get a lot of use and it will not sit on the shelves.
I am in holding pattern on this and since I don't ever invest my lifesaving on any stock, I have the padding to add if I need to. There is no way that I will dump it pre approval.
If I was in charge of a giant medical company, I would buy this robot over ever more unpredictable biotechs and pay the top dollars for it because it far cheaper to buy one than develop one which would take couple of decades and even then it is not guaranteed to be the right product and timed for the market. Mechanical devices are not easy to design and they are extremely corky and that is why there is only a few that have got to this level. Any company that has to develop a new one from the scratch will take a decade or two to make something that is better than the rest, the complexity will be even more in future because there would be existing competitors.
Stop pushing that date.
You had said "My Cousin works at Medtronic in Minn. Anyway he said there has been several cars in the parking lot lately which have Canadian license plates"
These shorts are pushing TTLIF to dump it on the longs.
They are buying $17 USD strike price and they can not even hold the $2 stock.
Now that is a real case of ROLFMAO.
Good point
No I don't think that. It is not material argument now at this stage.
CMR's Versius robot is really a Japanese robot made by Kawasaki Robotics. The hollow wrist clean robots are nothing new and revolutionary. They date back to 1970s and used for many applications and as the precision has been improved, they are applying it for surgery.
The robot was not designed out of blue in 5 years, They are some other company's robot made to spec. In other word, it is an old robot made smaller for some European company's spec .
It has never been a secret. It is multi armed and British private capital behind making it. They are taking an old device and making it work for a new application.
Now is it better than DaVinci? Is it better that other the new ones? It is yet to be be seen.
It is not a competition for a single port robot.
Are you offering it?
Who is the buyer and what is the competitors' offer? It is more complex that asking few posters online.
Companies do not operate by polling their investors as to what to do. It just does not work the way you think. I am surprised that you are asking this over and over.
It is managers and CEOs duty as officers of the company to work on commercialization path of their products unless there is an offer that the company and shareholders can't refuse.
It is not an either/ or situation at all.
Harb,
Short data is not predictive at all. When I was younger and looking for the holy grail in trading, I spent many hours of my spare time developing algorithms to trade stocks based on this type of crap, and short data was one of them. Higher or lower short shares is not predictive of lower or higher stock price, period. That was my conclusion then and it still applies. It totality of the market short/long level may have some implication on the trend for the 'market' but not individual stocks but even that can backfire either way.
Here is a mini-proof for you to abandon this analysis that the shorts dumping here because their gains have evaporated and they are desperate.
I will even use the site that some short here posted.
This is a random stock that I picked that has dropped about 10% today. Do you see the % short level signalling it? nope
https://www.algowins.com/?wdt_column_filter%5B1%5D=FNKO
This is a semi stock that I have followed for many years. Do you see any relationship with % short levels and stock price? Nope
https://www.algowins.com/?wdt_column_filter%5B1%5D=XLNX
This is the road that everybody who have ever traded stocks has traveled and it goes to nowhere pretty fast.
IDE submission
"An IDE application is considered approved 30 days after it has been received by the FDA, unless the FDA otherwise informs the sponsor via email prior to 30 calendar days from the date of receipt, that the IDE is approved, approved with conditions, or disapproved.
"
https://www.fda.gov/medical-devices/device-advice-investigational-device-exemption-ide/ide-approval-process
According to Titan
"
IDE Approval Q4 2019
Submit 510(k) Application H1 2020
Submit Technical File for CE Mark H1 2020
Anticipated Regulatory Clearance H2 2020
Projected Initial Launch H2 2020
"
https://titanmedicalinc.com/wp-content/uploads/2019/09/Titan-Medical-Investor-Presentation-September-4-2019.pdf
Last Day of Q4 is last Day of December
So they can submit the IDE any time between now and the last week of November in Q4 to get ID approval in Q4 so it does not have to be the first days of Q3
The degeneration of officers of this company by traders is not material argument at all.
The superior and complex high tech robot that they have designed would not have been possible in absence of knowledgeable and competent staff, period.
The amount of time that they have taken to produce it is function of complexity of the product and it takes that long and there would have been builtin expectation of slippage of many deadlines for any complex mechanical hardware and all their competition would have and will go through it just same. That is why there is not millions of these types of robots going for FDA approvals.
No other surgical robot of similar complexity has been designed in a shorter time in fact. Most of them have abandoned multiple generations of robots without having anything marketable till recently. That is why J&J and Medotronics have taken this long although they have spent billions of dollars internally to build them and they had started way before Titan. Their slippage are not exposed because they are giant companies that can write off their risky assets.
Rotflmfao as much as you want. No claim about past slippage makes your estimates and your claims to have any validity because you are not the officer the company to provide estimates.
The company is the only entity that can provide the valid estimates to the public.
The company is on the track of applying FDA approvals next Q.
From their presentation.
Established US & EU Centers of Excellence 2018
Proven Feasibility 2018
Integrated Simulation Training 2018
Engineering Confidence Build 2019
Design Freeze 2019
Commence GLP Animal Studies 2019
IDE Approval Q4 2019
Submit 510(k) Application H1 2020
Submit Technical File for CE Mark H1 2020
Anticipated Regulatory Clearance H2 2020
Projected Initial Launch H2 2020
https://titanmedicalinc.com/wp-content/uploads/2019/09/Titan-Medical-Investor-Presentation-September-4-2019.pdf
Actually that would be illegal insider trading.
If a company was in partnership or not , a company can issue options and warrants to its valued employees at any time.
Currently some employees may own some warrants that are in money and they don't execute it either till the time comes.
No company is going to plan its future based on assumption of a buyout because that would be in fact pure incompetence.
CEO's job is to set a path for success of company based on many possible paths in future but all of them require support and sales.
A tech company sets a plan based on events that are related to design and sale of it products and it there is buyout then the path is modified and not otherwise.
Exactly... I am with you on that.
I feel that a new competition entering the surgical robotic market will be good for Titan in general because they all serve a different criteria for surgeries and the market will become more accepting.
Be wary of any date related goal that is planted by traders. You don't know what their goals really are.
I never pay any attention to any of this stuff but act on the results.
TMDI has a very low market cap for a very high tech product that it has put together and you shorts are not entitled to steal from it and claim that longs would be cheated so that you shorts can steal from it even more.
It is up to longs to contest the financing and I am a long and I am happy to allow them to get funding by using the tools that the market provides for them to get financing to complete the FDA approvals because the end result would be far more valuable.
I doubt that the longs would prefer the shorts to steal from them so the cash goes into their pockets instead.
The dialog to encourage longs to sell at finish line is deceptive nonsense.
Exactly. The shorts have no say in that in any case because they are not the stock holders.
To add to that. There is no guarantee that retail stock holders won't lie. They can be shorts or trying to accumulate. There is no guarantee that institutions are not involved in any of this.
Obviously if the argument is that the options for insiders are not fair to investors then that would apply to entire US stock market and there is no real mechanism in markets to object and if there was, it is not here.
I like to see such a argument be made for giant company executives who are now billionaires like Amazon, Facebook, Microsoft, etc . Where were the laws to extracting billions into their own pocks worth trillions.
This arguments being made for this puny sized TMDI is pedantic and self serving nonsense by those who admittingly want to steal from the longs here and the shorts have been stealing marketcap in millions here .
The marketcap of TMDI does not belong to shorts to give it away and neither have they any case for claiming to have been cheated because they have been stealing the market cap.
Please note that 2 of the new analyst ratings are few weeks old and the other is couple of months old. There was no analyst rating for TDMI when I purchased this stock.
So Titan's street rating has gone up from no-ratings to all analyst-buys of triple of its current value aka strong-buy.
There is no sell or hold rating for TMDI while there are many of those for many other stocks.
Typically stocks with low marketcap do not get analyst ratings because they are speculative. They have high hopes for this one.
Analyst Forecasts
3 analysts : Buy
Consensus Forecast : $5.33
https://quotes.wsj.com/TMDI/research-ratings
When shorts get destroyed by an unexpected rise in one or many stocks, they have to cover, they have to extract cash just to survive so they have to close their trades before the market opens.
Shorting is pretty high risk specially with low volume stocks and possible pending news.
Titan has never been correlated with the market. Most low volume stock don't correlate with the market.
Stock 1 tmdi
Stock 2 msft
Start Date 2018-09-11
End Date 2019-09-11
# Prices 252
Correlation Coefficient -0.0652
Mustang, some open surgeries can not be even be attempted successfully because so much tissue has to be cut to access the region or tumors, etc and therefore they have very high mortality rate specially for people who are already frail.
Soon of later these robots are going to be used for a lot of complex surgeries.
Analyst Forecasts
3 analysts : Buy
Consensus Forecast : $5.33
https://quotes.wsj.com/TMDI/research-ratings
Titan has never been correlated with the market. Most low volume stock don't correlate with the market.
Stock 1 tmdi
Stock 2 msft
Start Date 2018-09-11
End Date 2019-09-11
# Prices 252
Correlation Coefficient -0.0652
I see. Now I understand what you meant.
Of course for the foreseeable future the big guys who have large amount of capital, have to purchase new technology to stay relevant.
Also cash can get devalued and so assets are more valuable to own at this time. Newer technology assets are better than older technology assets so they would be interested.
If they don't spend their money on new FDA approved products, where would they spend it.
I apologize. I misunderstood your proposition.
I thought that you meant that ISRG has locked up the market.